期刊
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
卷 187, 期 1, 页码 11-17出版社
ELSEVIER
DOI: 10.1016/j.resp.2013.02.004
关键词
Phosphodiesterase; Theophylline; Methylxanthines; Selective PDE inhibitors; Airways; Bronchial asthma
资金
- Center of Experimental and Clinical Respirology (CEKR1 and CEKR2)
- Virtual and Simulation Tuition as a new form of education at JFM CU in Martin
- EU
- Ministry of Education in Slovak Republic VEGA [1/0030/11, 1/0057/11]
Phosphodiesterases (PDEs) are known as a super-family of 11 isoenzymes, which can exert various functions based on their organ distribution. Aside from non-selective PDE inhibitors (methylxanthines, e.g. theophylline) used many years in clinical settings, increasing attention is focused on the involvement of selective PDE inhibitors in therapy of obstructive airway diseases associated with chronic inflammation. There are mostly PDE3, PDE4, and PDE7 isoforms present in the respiratory system. This paper describes the mechanisms of action, adverse effects, and potential clinical use of both non-selective and selective PDE inhibitors. The focus of the review is on the influence of PDE inhibitors on the immune system. (c) 2013 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据